term
myocard
describ
presenc
inflammatori
cell
myocardium
descript
diagnosi
encompass
wide
spectrum
etiolog
differ
diseas
share
uniqu
criterion
presenc
myocardi
inflamm
fig
term
howev
specifi
type
inflamm
natur
inflammatori
cell
caus
clinic
practic
diagnosi
myocard
impli
observ
phenotyp
attribut
inflamm
myocardium
myocardi
inflamm
constitut
comorbid
complic
preexist
known
heart
diseas
even
noninflammatori
natur
unlik
organ
tissu
myocardium
host
lymphoid
tissu
eg
balt
lung
malt
gastrointestin
tract
possess
resid
reticuloendotheli
cell
eg
liver
spleen
alveolar
macrophag
lung
glia
cell
brain
glomerularmesangi
cell
kidney
howev
fair
amount
steadyst
resid
macrophag
present
myocardi
tissu
macrophag
origin
yolk
sac
fetal
monocyt
progenitor
either
replenish
local
prolifer
infanc
blood
monocyt
adulthood
birth
resid
macrophag
express
major
histocompat
complex
class
ii
hla
ii
molecul
fractalkin
receptor
therefor
distinct
convent
integrin
dendrit
cell
age
number
hla
ii
macrophag
increas
number
macrophag
decreas
prolifer
capac
embryoderiv
cardiac
macrophag
progress
declin
perinat
period
cardiacresid
macrophag
display
distinct
function
properti
monocytederiv
macrophag
cardiac
tissu
resid
macrophag
interweav
complex
molecular
dialogu
cardiac
myocyt
like
mediat
cytokin
macrophag
modul
differ
signal
origin
injur
cardiac
tissu
cardiac
inflammatori
diseas
resid
macrophag
like
particip
attract
circul
monocyt
inflammatori
cell
depend
local
signal
trigger
inflamm
therefor
myocardi
tissu
lack
immun
defens
structur
system
like
organ
much
commonli
target
infect
myocardi
tissu
becom
target
inflamm
repair
tissu
damag
eg
acut
myocardi
infarct
toxic
necrosi
myocyt
infect
cardiotrop
pathogen
infect
myocard
allogen
condit
eg
transplant
cardiac
structur
valv
pericardium
becom
target
inflamm
due
selfpathogen
mimicri
mechan
eg
rheumat
fever
becom
selfreact
immunemedi
myocard
genet
defect
induc
defici
immunolog
system
eg
primari
immunodefici
autoinflammatori
diseas
understand
mechan
myocardi
inflamm
infecti
noninfecti
myocard
challeng
difficult
understand
whether
individu
constitut
gene
variant
influenc
mechan
fact
note
individu
expos
pathogen
may
may
develop
myocard
even
within
environment
exposur
context
one
reason
search
predispos
genet
factor
continu
attract
interest
research
chapter
briefli
review
main
type
myocard
discuss
individu
genet
suscept
differ
type
myocard
clinic
research
develop
perspect
type
myocard
review
chapter
book
overal
myocard
simpli
group
infecti
noninfecti
autoimmun
immunemedi
autoinflammatori
toxic
etiolog
tabl
infecti
myocard
caus
dna
rna
virus
bacteria
fungi
protozoa
helminth
common
caus
infecti
myocard
children
adult
cardiotrop
virus
nonvir
cardiotrop
infect
trypanosoma
cruzi
chaga
diseas
borrelia
burgdorferi
lyme
diseas
affect
immunecompet
individu
endem
area
immunocompromis
patient
typic
heart
transplant
recipi
common
opportunist
infect
includ
human
cytomegaloviru
hcmv
toxoplasma
gondii
state
knowledg
etiolog
diagnosi
manag
therapi
myocard
diagnosi
manag
myocardi
involv
system
immunemedi
diseas
report
two
posit
statement
european
societi
cardiolog
precis
rule
defin
criteria
diagnosi
system
organ
involv
includ
heart
myocardi
involv
diagnos
infecti
agent
detect
myocardi
tissu
patholog
pathogenrel
genom
studi
often
clinic
practic
diagnosi
myocard
suspect
base
clinic
biochem
imag
criteria
demonstr
myocardi
tissu
inflamm
failur
precis
diagnos
caus
lead
overlook
potenti
toxic
origin
eg
pheochromocytoma
genet
famili
diseas
similar
clinic
express
resuscit
cardiac
arrest
one
exampl
imagingdetect
interstiti
edema
lead
incorrect
diagnost
hypothes
expect
infecti
myocard
genet
diseas
absenc
pathogen
myocard
howev
role
genet
suscept
repeatedli
rais
clinic
experiment
studi
attempt
understand
individu
develop
myocard
other
perhap
expos
risk
case
appar
sporad
myocard
patient
primari
immunodefici
diseas
pid
mainli
autosom
recess
predispos
infect
includ
caus
myocard
pid
phenotyp
heterogen
overal
genet
caus
infect
condit
immunodefici
underli
predisposit
occurr
myocard
pid
predominantli
observ
pediatr
age
case
child
dissemin
mycobacterium
avium
infect
carrier
defici
due
compound
heterozygos
ultim
die
acut
heart
failur
due
coxsacki
myocard
poor
nutrit
statu
adult
rarer
possibl
tolllik
receptor
mutat
identifi
adult
patient
diagnos
enterovir
ev
myocard
possibl
deep
molecular
genet
explor
heart
diseas
may
contribut
unravel
molecular
pathogenet
mechan
heart
diseas
either
predisposit
genet
cardiomyopathi
infect
may
trigger
first
manifest
diseas
simpli
infecti
complic
patient
establish
diagnosi
genet
cardiomyopathi
question
whether
genet
affect
heart
vulner
inflammatori
trigger
nonaffect
heart
recent
vitro
clinic
studi
explor
hypothesi
human
genet
factor
might
underli
acut
viral
myocard
previous
healthi
children
author
test
role
ifn
immun
use
humaninduc
pluripot
stem
cellderiv
cardiomyocyt
ipsccm
perform
wholeexom
sequenc
unrel
children
acut
myocard
proven
viral
etiolog
ipsccm
show
suscept
coxsackieviru
infect
control
cell
induc
gene
control
cardiomyocyt
exogen
substanti
protect
cardiomyocyt
exom
sequenc
show
mutat
gene
unexpectedli
seven
patient
carrier
rare
biallel
nonsynonym
splicesit
variat
six
cardiomyopathyassoci
gene
dsp
author
conclud
previous
silent
recess
defect
myocardium
may
predispos
acut
heart
failur
present
acut
myocard
notabl
common
viral
infect
hypothesi
acut
myocard
reflect
activ
phase
arvd
lead
chang
phenotyp
abrupt
progress
diseas
investig
lopezayala
colleagu
suggest
activ
phase
suspect
patient
myocard
associ
famili
histori
arvd
certain
mutat
may
increas
suscept
superimpos
myocard
arvd
patient
dilat
cardiomyopathi
caus
defect
dystrophin
dysferlin
demonstr
increas
suscept
myocardi
infect
enhanc
viral
propag
adjac
cardiomyocyt
disrupt
function
repair
myocyt
membran
histori
recent
flu
episod
patient
xldcm
caus
defect
dystrophin
may
confound
true
clinic
diagnosi
possibl
viral
flu
trigger
unmask
manifest
preexist
asymptomat
diseas
exclud
although
myocard
viral
genom
may
found
emb
patient
xldcm
myocardium
dystrophin
defect
could
sustain
greater
damag
coxsackieviru
proteas
known
affect
host
cell
protein
dystrophin
confirm
role
effect
myocard
express
dystrophin
evid
focal
disrupt
complex
dgc
human
coxsackieviru
b
myocard
dgc
disrupt
contribut
pathogenesi
human
enteroviru
ev
induc
dilat
cardiomyopathi
disintegr
sarcoglycan
complex
may
addit
dystrophin
cleavag
play
import
role
pathogenesi
enterovirusinduc
cardiomyopathi
clinic
present
ev
infect
may
rel
mild
fever
herpangina
conjunct
handfootmouth
diseas
tonsil
pharyng
lower
respiratori
tract
infect
acut
gastroenter
less
commonli
sever
pneumonia
mening
enceph
myocard
pericard
hepat
necrosi
coagulopathi
ev
myocard
often
describ
outbreak
ev
infect
tabl
cardiotrop
coxsackieviru
one
common
caus
myocard
myocardi
infect
initi
transmembran
coxsackievirusadenoviru
receptor
car
encod
cxadr
gene
experiment
model
ablat
car
block
viral
infect
myocardi
cell
well
inflamm
myocardium
similarli
increas
cardiac
express
car
may
partial
explain
increas
suscept
myocard
howev
date
mutat
cxadr
gene
reportedidentifi
myocyt
cell
damag
induc
direct
cytotox
mediat
viral
proteinas
replic
surfac
autophagosom
enhanc
replic
employ
mirna
differenti
express
mirna
modul
express
host
viral
gene
individu
genet
makeup
may
favor
ev
infect
recent
investig
focus
phosphatidylinositol
kinas
type
betaacylcoabind
domaincontain
protein
interact
facilit
mechan
effici
viral
replic
enterovirus
well
positivestrand
rna
virus
reorgan
host
cellular
membran
recruit
phosphatidylinositol
pi
whose
defect
caus
monogen
autosom
recess
perisylvian
polymicrogyria
cerebellar
hypoplasia
arthrogryposi
acut
inhibit
enzym
kinas
inhibitor
caus
sudden
death
golgiresid
protein
golgi
phosphoprotein
involv
mainten
golgi
structur
function
respons
proper
local
enterovir
protein
host
cell
mutant
abrog
interact
show
interact
crucial
enteroviru
replic
allow
identif
minim
domain
essenti
enteroviru
replic
therefor
acylcoenzym
bind
acb
chargedaminoacid
region
car
domain
dispens
recruit
effici
enteroviru
replic
myocardi
express
nucleotidebind
oligomer
domain
protein
gene
also
found
higher
patient
compar
patient
myocard
without
evid
persist
infect
genet
variant
gene
report
date
human
parvoviru
belong
genu
erythroparvoviru
parvovirida
famili
compos
group
dna
virus
linear
singlestrand
dna
genom
infect
human
erythroid
progenitor
cell
epc
caus
mild
sever
hematolog
disord
may
also
infect
nonerythroid
lineag
cell
myocardi
endotheli
cell
tropism
epc
depend
express
viral
receptor
coreceptor
cell
surfac
viral
use
host
factor
rna
bind
motif
protein
process
premrna
viral
replic
variant
gene
report
far
protein
code
gene
interact
intron
splice
enhanc
element
premrna
promot
protein
express
regul
proteinmedi
augment
replic
complex
enter
cell
endocytosi
process
mediat
direct
interact
antibodybound
complement
factor
receptor
cell
surfac
infect
caus
fifth
diseas
arthropathi
anemia
immunocompromis
patient
sickl
cell
diseas
patient
myocard
hydrop
fetali
pregnant
women
cardiac
manifest
vari
mild
nonspecif
symptom
eg
fatigu
arrhythmia
sever
includ
cardiogen
shock
requir
mechan
support
pcrbase
studi
report
genom
myocardi
tissu
patient
myocard
dilat
cardiomyopathi
howev
also
control
case
disprov
hypothesi
persist
myocardi
viral
infect
might
frequent
caus
dcm
myocard
similar
find
report
skin
sampl
patient
dermatolog
diseas
role
viral
infect
debat
consid
biopsi
tissu
sampl
bloodfre
addit
remnant
dna
strand
releas
tissu
without
activ
viral
replic
therefor
pcrbase
detect
dna
blood
prove
presenc
infecti
virion
viral
replic
find
suggest
caution
interpret
role
infect
base
dna
detect
blood
myocard
also
diseas
hypothes
causal
link
final
viral
load
genom
myocardium
relat
longterm
outcom
possibl
hypothesi
could
explain
role
myocard
cardiomyopathi
potenti
trigger
effect
viral
genom
innat
immun
induc
proinflammatori
cytokin
secret
myocardi
inflamm
although
hypothesi
individu
suscept
modifi
gene
may
influenc
predisposit
myocard
current
proven
evid
gene
variant
potenti
exert
role
recent
describ
case
myocard
patient
chromosom
integr
link
herp
viru
infect
inherit
risk
myocard
rare
herit
condit
complet
genom
viru
integr
host
germlin
genom
omim
character
high
viral
copi
number
blood
sera
log
copiesml
preval
uk
blood
donor
therefor
find
high
viral
load
healthi
normal
individu
highlight
need
correctli
interpret
possibl
confound
effect
laboratori
diagnosi
infect
role
patient
dcmheart
failur
integr
viral
genom
eventu
secret
viral
chemokin
confer
human
gene
link
inflammatori
patholog
support
reactiv
sourc
emerg
infect
chaga
diseas
cd
caus
protozoan
parasit
trypanosoma
cruzi
direct
oral
contact
contamin
blood
transfus
bone
marrow
transplant
may
also
vertic
transmiss
mother
infant
cd
endem
southern
usa
mexico
central
america
south
america
contamin
food
drink
report
northern
south
america
transmiss
cycl
may
involv
wild
vector
popul
mammalian
reservoir
host
acut
phase
diseas
manifest
myocard
conduct
system
abnorm
pericard
untreat
patient
diseas
progress
chronic
phase
develop
chronic
chaga
cardiomyopathi
ccc
genet
suscept
develop
ccc
matter
ongo
investig
immun
gene
identifi
possibl
individu
populationbas
predisposit
tabl
list
gene
relat
variant
investig
date
cd
although
associ
studi
test
posit
genet
test
current
perform
diagnost
workup
cd
genet
suscept
repeatedli
claim
contributor
pathogenesi
rhd
date
signific
result
identifi
reproduc
gwa
studi
rheumat
fever
exampl
famili
nongenet
aggreg
difficulti
distinguish
famili
genet
suscept
transient
persist
environment
factor
member
famili
may
expos
histor
research
focus
attent
famili
aggreg
explor
field
immunogenet
earli
studi
publish
natur
identifi
bcell
alloantigen
marker
patient
previous
diagnos
rf
without
subsequ
rhd
antigen
b
cell
found
patient
type
new
york
patient
type
bogota
compar
two
diseasefre
control
group
marker
associ
known
major
histocompat
complex
mhc
antigen
later
studi
show
two
antibodi
produc
antigen
present
patient
compar
diseasefre
control
anoth
monoclon
antibodi
label
identifi
bcell
antigen
present
rf
patient
found
unaffect
sib
parent
respect
segreg
phenotyp
percentag
cell
within
hlatyp
rheumat
fever
famili
consist
autosom
recess
inherit
associ
mhc
gene
system
antibodi
later
consid
diseasespecif
marker
worldwid
distribut
may
serv
diagnost
tool
patient
suspect
rheumat
fever
therefor
hypothesi
autosom
famili
recess
predispositionsuscept
relat
hla
gene
remain
doubt
nonetheless
recent
twin
pair
studi
demonstr
concord
risk
acut
rheumat
fever
monozygot
twin
dizygot
twin
estim
herit
across
six
metaanalyz
studi
genet
variant
associ
increas
risk
rhd
investig
basi
hypothesi
cytokin
gene
polymorph
could
play
role
suscept
rhd
patient
significantli
associ
increas
risk
rhd
c
associ
modifi
rhd
risk
thereaft
research
focus
role
function
variant
gene
encod
molecul
complement
activ
pathway
rational
tissu
damag
rhd
mediat
autoantibodi
result
molecular
mimicri
ga
cardiac
tissu
protein
ga
molecul
glcnac
protein
crossreact
valv
myocyt
protein
host
glcnac
immunodomin
cell
wall
antigen
epitop
ga
recogn
ficolin
compris
patternrecognit
receptor
prr
complement
three
human
ficolin
mficolin
lficolin
hficolin
also
known
hakata
antigen
found
solubl
form
cell
membran
bind
sialic
acid
capsular
polysaccharid
pathogen
includ
streptococcu
agalactia
level
express
influenc
promot
gene
variant
associ
increas
gene
express
whole
blood
adipos
subcutan
tissu
also
associ
increas
protect
diseas
polymorph
may
play
dual
role
physiopatholog
rf
one
hand
increas
ga
infect
predispos
patient
rhd
symptom
infect
establish
polymorph
associ
low
level
lficolin
level
may
predispos
carrier
recurr
andor
sever
streptococc
infect
low
level
level
report
rhd
interpret
effect
consider
consumpt
rf
tabl
case
promis
therapeut
target
autoimmun
diseas
gene
defect
associ
immunodefici
due
defici
mim
autosom
recess
diseas
character
increas
suscept
infect
autoimmun
diseas
defect
lectin
activ
pathway
complement
system
specif
biomark
decreas
serum
level
defici
rare
diseas
major
scientif
clinic
interest
heterozyg
carrier
reduct
circul
level
date
one
case
cardiac
diseas
describ
male
infant
oper
repair
congenit
heart
defect
final
possibl
exist
patient
genet
diseas
suscept
rf
new
area
clinic
observ
also
deserv
attent
due
increas
number
genet
diseas
correctli
diagnos
exampl
figur
show
case
fatal
rheumat
pancard
boy
osteogenesi
imperfecta
fig
blau
syndrom
earlyonset
chronic
granulomat
autoinflammatori
diseas
inherit
autosom
domin
pattern
origin
clinic
manifest
describ
triad
constitut
granulomat
dermat
arthriti
uveiti
addit
manifest
includ
erythema
nodosum
fever
sialaden
lymphadenopathi
leukocytoclast
vascul
transient
neuropathi
granulomat
glomerular
interstiti
nephriti
interstiti
lung
diseas
arteri
hypertens
pulmonari
hypertens
pericard
pulmonari
embol
hepat
granuloma
splenic
involv
chronic
renal
failur
cardiac
involv
rare
patholog
hallmark
noncas
epithelioid
cell
blau
granuloma
blau
syndrom
caus
mutat
caspas
recruit
domain
gene
chromosom
mutat
systemat
collect
intern
infev
registri
fmfighcnrsfrinfev
blau
syndrom
allel
earlyonset
sarcoidosi
eo
diagnosi
usual
suspect
clinic
context
rheumatolog
dermatolog
ophthalmolog
issu
unusu
patient
manifest
cardiac
involv
onset
cardiologist
like
involv
clinic
manag
patient
diagnos
diseas
myocard
specif
mention
complex
phenotyp
diseas
pericard
known
possibl
complic
myocardi
involv
cardiac
infiltr
report
earlyonset
sarcoidosi
associ
mutat
outsid
blau
syndrom
eo
sarcoidosi
usual
consid
autoimmun
diseas
possibl
famili
suscept
way
conform
classic
mendelian
mode
inherit
suscept
loci
gene
identifi
date
summar
tabl
snp
major
histocompat
complex
hladra
gene
associ
suscept
sarcoidosi
recent
multipopul
studi
demonstr
least
part
associ
independ
unrel
linkag
disequilibrium
share
across
ancestr
origin
variant
independ
associ
act
equantit
trait
loci
andor
suggest
role
regul
gene
express
gene
variant
seem
predispos
factor
sarcoidosi
except
caucasian
postmenopaus
women
sarcoid
uveiti
gg
genotyp
prevail
loci
associ
genet
suscept
sarcoidosi
pend
mani
candid
gene
report
yet
confirm
ace
tnfa
gene
influenc
clinic
present
sarcoidosi
like
differ
underli
diseas
suscept
date
genet
test
enter
clinic
diagnost
path
sarcoidosi
wholeexom
sequenc
studi
identifi
rare
genet
variat
famili
pulmonari
sarcoidosi
familybas
exom
sequenc
studi
identifi
plausibl
function
rare
genet
variant
among
german
famili
find
highlight
calcium
ionrel
biolog
activ
immun
respons
gene
possibl
involv
pathway
immuneinflammatori
respons
regul
leukocyt
prolifer
defens
respons
bacteria
among
major
mechan
kegg
pathway
map
analysi
indic
inflammatori
bowel
diseas
relev
complex
phenotyp
sever
chronic
clinic
cours
overlap
concurr
lung
diseas
partli
explain
difficulti
encount
studi
investig
genet
basi
sarcoidosi
clinic
level
use
awar
risk
recurr
sarcoidosi
rel
affect
patient
access
studi
case
control
etiolog
sarcoidosi
studi
demonstr
firstdegre
rel
patient
sarcoidosi
five
time
higher
rel
risk
develop
sarcoidosi
control
subject
recent
studi
swedish
nation
patient
regist
use
intern
classif
diseas
code
confirm
least
one
firstdegre
rel
sarcoidosi
associ
increas
risk
sarcoidosi
rel
risk
increas
two
rel
rel
risk
syndrom
rel
risk
percentag
herit
ci
therefor
rel
sarcoidosi
strong
risk
factor
diseas
clinic
practic
famili
histori
uveiti
lung
diseas
particular
explor
aim
verifi
whether
famili
member
diagnos
sarcoidosi
instead
japanes
popul
sarcoidosi
particularli
frequent
occurr
cardiac
sarcoidosi
femal
patient
associ
presenc
allel
loci
formal
list
omim
catalogu
describ
tabl
genet
variant
investig
sarcoidosi
report
tabl
giant
cell
myocard
gcm
rare
potenti
fatal
ill
unknown
etiolog
character
myocardi
inflamm
multinucl
giant
cell
myocyt
necrosi
gcm
current
consid
multifactori
diseas
trigger
differ
caus
etiolog
hypothes
includ
system
autoimmun
diseas
drug
toxic
infect
complex
combin
autoimmun
infect
drug
toxic
infect
report
gcm
includ
coxsacki
viru
parvoviru
hcmv
infect
case
gcm
isol
entiti
onefifth
case
gcm
occur
associ
autoimmuneimmunemedi
diseas
tabl
infect
drug
toxic
syndrom
immun
reconstitut
inflammatori
syndrom
iri
patient
undergo
highli
activ
antiretrovir
therapi
haart
human
immunodefici
viru
type
even
patient
take
common
medic
amoxicillin
date
autoimmuneimmunemedi
hypothesi
accredit
pathogen
theori
support
aforement
associ
system
autoimmun
diseas
tabl
partial
remiss
gcm
patient
treat
immunosuppress
well
nonaggress
occurr
diseas
immunosuppress
treatment
transplant
patient
clinic
manifest
gcm
variabl
patient
present
cardiogen
shock
acut
heart
failur
requir
mechan
circulatori
support
howev
conduct
diseas
atrioventricular
nodal
infranod
heart
block
atrial
ventricular
arrhythmia
first
manifest
rare
atrial
variant
character
atrial
fibril
sever
atrial
dilat
preserv
ventricular
function
precis
diagnosi
gcm
establish
typic
patholog
featur
demonstr
emb
surgic
sampl
fig
inflammatori
infiltr
constitut
lymphocyt
eosinophil
multinucl
giant
cell
myocyt
show
damag
necrosi
origin
giant
cell
myocyt
andor
histiocyt
remain
matter
investig
differenti
diagnosi
gcm
cardiac
sarcoidosi
reli
patholog
featur
noncas
epithelioid
granuloma
giant
cell
sarcoidosi
support
differ
tcell
subset
sarcoidosi
gcm
gcm
carri
poor
prognosi
median
surviv
month
onset
symptom
patient
either
die
requir
cardiac
transplant
data
manag
includ
medic
mechan
circulatori
support
bridg
recoveri
transplant
given
dedic
chapter
book
occurr
gcm
mendelian
diseas
either
underreport
unexplor
anecdot
extrem
rare
myocard
giant
cell
hepat
diagnos
patient
spinal
muscular
atrophi
respiratori
distress
genet
caus
nonsens
mutat
immunoglobulinmubind
protein
diseas
gene
mutat
gene
typic
caus
autosom
recess
diseas
axon
type
distal
hereditari
motor
neuronopathi
type
iv
evid
causal
link
gcm
genet
defect
rather
repres
possibl
complic
diseas
associ
gcm
myasthenia
gravi
mg
thymoma
warrant
special
mention
two
reason
fair
number
report
gcm
patient
myasthenia
gravi
associ
giant
cell
polymyos
myocard
myasthenia
gravi
thymoma
possibl
respons
myositi
novel
biolog
drug
rituximab
steroid
acetylcholinesteras
inhibitor
immunosuppress
agent
fail
cardiomyos
subclin
cardiac
dysfunct
describ
patient
thymoma
lateonset
myasthenia
gravi
date
gene
express
studi
identifi
diseas
gene
rather
contribut
unravel
pathophysiolog
mechan
diseas
cardiac
gene
express
profil
reveal
upregul
gene
involv
tcell
immun
respons
major
upregul
gene
involv
tcell
activ
subset
plakoglobin
express
reduc
gcm
cardiac
sarcoidosi
well
arvc
lymphocyt
myocard
redistribut
plakoglobin
intercellular
junction
intracellular
locat
attribut
mediat
tnfalpha
consid
mediat
granulomat
myocard
he
somat
genet
mutat
fusion
account
minor
case
median
rang
develop
countri
fusion
occur
approxim
patient
idiopath
hypereosinophilia
usual
young
adultsadult
less
commonli
children
elderli
patient
fusion
myeloprolif
variant
male
eosinophilia
subtyp
show
gender
differ
rearrang
far
less
common
clinic
present
he
heterogen
nonspecif
weak
fatigu
dyspnea
myalgia
angioedema
rash
fever
rhiniti
diarrhea
patient
demonstr
leukocytosi
eg
higher
eosinophilia
rang
neutrophilia
basophilia
myeloid
immatur
matur
immatur
eosinophil
vari
degre
dysplasia
anemia
occur
patient
thrombocytopenia
bone
marrow
eosinophilia
crystal
possibl
increas
blast
marrow
fibrosi
also
recur
skin
commonli
affect
tissu
patient
follow
lung
gastrointestin
manifest
case
respect
cardiac
involv
occur
patient
affect
myocardium
endocardium
valv
releas
toxic
mediat
interstiti
eosinophil
associ
heart
failur
endocardi
infiltr
caus
mural
thrombi
increas
embol
risk
late
phase
character
endocardi
fibrosi
manifest
restrict
physiolog
valv
regurgit
occur
mural
endocardi
thrombosi
fibrosi
involv
mitral
tricuspid
valv
leaflet
cardiac
involv
major
caus
morbid
mortal
he
diseas
cours
divid
three
stage
acut
necrot
stage
thrombot
stage
fibrot
stage
earli
acut
necrot
stage
character
eosinophil
lymphocyt
infiltr
eosinophil
undergo
degranul
myocardi
interstitium
releas
biolog
activ
factor
caus
myocyt
injuri
fig
thrombot
stage
mural
thrombi
stratifi
endocardium
endocardi
thrombophilia
like
promot
releas
antifibrinolyt
mediat
thrombomodulineosinophil
protein
impair
anticoagul
properti
endocardi
cell
thrombi
commonli
involv
ventricular
apex
extend
subvalvular
region
occasion
atria
scar
fibrot
stage
ventricl
subvalvular
structur
atrioventricular
valv
involv
function
phenotyp
typic
restrict
endomyocardi
fibrosi
egpa
system
necrot
vascul
affect
smalltomediums
vessel
egpa
belong
group
antineutrophil
cytoplasm
antibodi
anca
associ
vascul
aav
character
blood
tissu
eosinophilia
asthma
thu
distinct
granulomatosi
polyangi
wegen
microscop
polyangi
anca
posit
rang
egpa
patient
usual
less
frequent
observ
aav
diagnost
manag
algorithm
egpa
report
correspond
chapter
book
although
repeatedli
mention
review
articl
contribut
germlin
mutat
egpa
remain
elus
report
describ
famili
cluster
egpa
sib
pair
brother
sister
two
sister
father
son
precis
caus
unknown
genet
determin
contributor
remain
unexplor
howev
except
case
organ
transplant
ident
twin
differ
reaction
medic
seem
exclud
genet
basi
predisposit
egpa
one
pair
twin
one
affect
egpa
receiv
ident
twin
graft
rejectionfre
excel
clinic
result
second
exampl
pair
twin
affect
asthma
treat
drug
leukotrien
receptor
antagonist
instanc
suspect
caus
egpa
one
twin
develop
egpa
nevertheless
search
risk
factor
suscept
continu
object
interest
genet
studi
investig
group
aav
granulomatosi
polyangi
wegen
gpa
microscop
polyangi
mpa
syndrom
css
show
genet
variant
may
vari
three
group
aav
exampl
w
allel
confer
suscept
develop
gpa
mpa
css
snp
lepr
gene
posit
associ
wegen
granulomatosi
css
snp
gene
encod
chemokin
initi
describ
associ
diseas
suscept
later
found
predict
risk
diseas
irrespect
fact
serum
sensit
specif
marker
diagnosi
activ
css
suitabl
routin
clinic
practic
therefor
current
evid
support
role
genet
variant
suscept
egpa
children
omenn
syndrom
may
erythroderma
lymphadenopathi
eosinophilia
profound
immunodefici
hepatosplenomegali
failur
thrive
diarrhea
alopecia
common
laboratori
abnorm
eosinophilia
increas
ige
lymphocytosi
anemia
hypogammaglobulinemia
hypoproteinemia
reduc
lymphoprolif
respons
mitogen
characterist
patholog
includ
thymic
dysplasia
loss
bcellcontain
region
within
reticuloendotheli
system
extens
infiltr
eosinophil
interdigit
reticular
cell
spectrum
cardiac
involv
rang
myocard
hypertroph
cardiomyopathi
hcm
children
omenn
syndrom
cytomegaloviru
cmv
infect
often
run
asymptomat
caus
fatal
cmv
myocard
patholog
may
show
pancard
eosinophilrich
inflammatori
infiltr
myocardium
endomyocardi
biopsi
may
show
mild
lymphocyt
histiocyt
infiltr
lack
myocyt
hypertrophi
manifest
includ
biventricular
hypertrophi
impair
left
ventricular
systol
function
sever
sinu
bradycardia
possibl
secondari
endomyocardi
diseas
caus
eosinophilia
success
bone
marrow
transplant
bmt
report
patient
hypertroph
nonobstruct
cardiomyopathi
develop
bcg
infect
follow
neonat
vaccin
patient
xlink
agammaglobulinemia
xla
primari
immunodefici
caus
mutat
gene
code
bruton
tyrosin
kinas
btk
demonstr
defici
develop
b
lymphocyt
hypogammaglobulinemia
infect
common
clinic
present
follow
posit
famili
histori
neutropenia
myocardi
involv
rare
patient
commonli
manifest
otiti
pneumonia
sinus
chronicrecurr
diarrhea
conjunct
pyoderma
andor
cellul
meningitisenceph
sepsi
septic
arthriti
hepat
osteomyel
btk
inhibitor
use
treatment
leukemia
patient
expos
high
risk
pneumonia
risk
myocard
unknown
howev
polymorph
gene
code
fcg
riia
receptor
b
lymphocyt
growth
differenti
factor
increas
suscept
pneumonia
case
humor
immunodefici
antibodi
replac
therapi
may
indic
patient
hypogammaglobulinemia
inherit
acquir
expos
high
risk
infect
particular
control
humor
immun
picornavirida
infect
biallel
mutat
lrba
lipopolysacchariderespons
beigelik
anchor
protein
caus
primari
immunodefici
clinic
featur
rang
hypogammaglobulinemia
lymphoprolif
syndrom
inflammatori
bowel
diseas
heterogen
autoimmun
manifest
recent
report
describ
case
femal
affect
system
lupu
erythematosu
diagnos
year
admit
hospit
chest
pain
dyspnea
hypogammaglobulinemia
iatrogen
secondari
rituximab
treatment
key
clinic
diagnosi
myocard
caus
human
parechoviru
hpev
picornavirida
famili
rna
virus
diagnosi
myocard
clinic
suspect
confirm
endomyocardi
biopsi
ivig
therapi
prevent
enceph
patient
especi
children
affect
hematologiconcolog
disord
solid
organ
malign
appropri
treat
diseas
may
develop
neutropenia
decreas
serum
immunoglobulin
level
patient
risk
myocard
bacteri
viral
high
present
sign
heart
failur
myocard
consid
precis
diagnosi
presenc
myocard
caus
obtain
associ
mortal
even
patient
diseas
remiss
autosom
recess
diseas
character
sever
congenit
neutropenia
intermitt
thrombocytopenia
promin
superfici
venou
circul
congenit
heart
defect
atrial
septal
defect
asd
common
urogenit
malform
although
case
syndrom
nonsyndrom
form
also
report
descript
spectrum
phenotyp
expand
definit
phenotypegenotyp
establish
thu
far
recurr
mutat
identifi
nine
differ
patient
asd
type
treatment
granulocyt
colonystimul
factor
restor
absolut
neutrophil
count
neutrophil
function
compet
myocard
describ
howev
new
field
knowledg
given
cardiovascular
relev
possibl
manifest
nonsyndrom
phenotyp
must
least
known
cardiologist
report
hematologist
patient
present
neutropenia
andor
thrombocytopenia
andor
associ
chd
sd
autosom
recess
disord
character
bone
marrow
failur
exocrin
pancreat
dysfunct
two
kind
cardiac
involv
describ
cardiomyopathi
heart
failur
myocardi
fibrosi
histopatholog
necrosi
chd
recent
case
dilat
cardiomyopathi
refractori
heart
failur
report
girl
sd
patient
genet
proven
sd
cardiac
abnorm
six
cardiomyopathi
six
chd
patholog
substrat
systol
dysfunct
still
unexplor
sporad
case
describ
dcm
myocardi
fibrosi
howev
cardiac
evalu
also
major
clinic
need
cardiotox
chemotherapi
case
hematopoiet
stem
cell
transplant
hsct
cardiac
marker
potenti
predict
progress
heart
failur
circumferenti
strain
cc
abnorm
case
prior
hsct
undergon
hsct
normal
left
ventricular
eject
fraction
autoinflammatori
syndrom
ai
encompass
larg
group
diseas
clinic
character
recur
inflammatori
manifest
variabl
organ
involv
febril
episod
classif
complex
number
diseas
relat
genet
caus
continu
expand
term
autoinflamm
link
phenotyp
defect
innat
immunemedi
inflamm
distinguish
relat
diseas
caus
dysfunct
adapt
immun
function
ie
associ
autoimmun
disord
number
myocard
describ
autoinflammatori
diseas
low
reason
may
myocard
inde
rare
syndrom
set
myocard
may
occur
involv
organ
system
determin
phenotyp
cours
diseas
limit
knowledg
prevent
precis
phenotyp
descript
ai
myocardi
involv
nevertheless
myocard
deserv
mention
context
ai
occur
presenc
evolut
serious
alter
clinic
cours
patient
autoinflammatori
syndrom
includ
famili
mediterranean
fever
fmf
first
system
autoinflammatori
disord
genet
character
fmf
rare
autosom
recess
diseas
caus
homozyg
doubl
heterozyg
mutat
mefv
gene
encod
pyrin
anoth
system
autoinflammatori
disord
autosom
domin
receptorassoci
period
fever
syndrom
trap
identifi
discoveri
gene
encod
extracellular
domain
kda
tnf
receptor
fmf
trap
manifest
unexplain
fever
skin
rash
seros
arthralgia
variabl
combin
myocard
uncommonli
report
disord
autoinflammatori
syndrom
pericard
much
common
potenti
limit
distinct
myocard
pericard
autoinflamm
suscept
macrophageactiv
syndrom
ma
myocard
complic
underli
phenotyp
diseas
gene
diagnost
marker
high
level
result
spontan
induc
macrophag
activ
pyroptosi
howev
level
routin
measur
patient
suspect
myocard
therefor
diagnost
marker
rare
diseas
miss
clinic
practic
haploinsufficiencyrel
syndrom
gain
attent
new
associ
adultonset
still
diseas
aosd
condit
myocard
uncommon
aosd
rare
diseas
clinic
character
fever
arthriti
skin
rash
etiolog
unknown
recent
advanc
identif
caus
character
phenotyp
ai
lend
way
identifi
specif
caus
anticip
haploinsuffici
one
caus
ai
protein
encod
gene
critic
inhibitor
proinflammatori
signal
pathway
involv
neg
regul
autoinflamm
autoimmun
clinic
phenotyp
associ
heterogen
includ
autoimmun
diseas
diseas
hereditari
feverlik
condit
juvenil
idiopath
arthriti
system
lupu
erythematosu
rheumatoid
arthriti
recent
aosd
splice
site
mutat
gene
identifi
patient
previous
diagnos
adultonset
still
diseas
aosd
correctli
diagnos
patient
success
treat
receptor
biolog
tocilizumab
myocard
repeatedli
report
aosd
present
myocarditispericard
pericard
occur
case
coronari
arter
also
describ
case
diagnosi
myocard
formul
basi
clinic
biochem
imag
criteria
appropri
endomyocardi
biopsi
studi
howev
perform
distinguish
pericard
myocard
mostli
chronic
consequ
differ
irrespect
caus
interferonmedi
autoinflammatori
diseas
type
interferonopathi
ifnmedi
autoinflammatori
diseas
imad
defin
chronic
excess
type
interferon
ifn
product
includ
group
syndrom
ag
cardiomyopathi
phenotyp
part
spectrum
clinic
manifest
diseas
tabl
ag
character
hypothyroid
chilblain
glaucoma
cardiomyopathi
intracerebr
vascul
peripher
neuropathi
bowel
inflamm
system
lupu
erythematosu
agss
type
autoinflammatori
diseas
caus
mutat
gene
involv
nucleic
acid
metabolismsign
adar
manifest
utero
diseas
onset
postnat
present
usual
within
first
year
life
subacut
encephalopathi
tabl
patholog
affect
heart
still
larg
unexplor
cardiac
involv
describ
infantileonset
hypertroph
cardiomyopathi
hypothyroid
demyelin
peripher
neuropathi
whether
patholog
substrat
cardiomyopathi
inflammatori
origin
still
unknown
absenc
one
known
diseas
gene
caus
ag
mice
caus
myocard
enzym
degrad
endogen
retroel
thu
link
autoimmun
diseas
mous
fdaapprov
drug
inhibit
revers
transcriptas
improv
myocard
indic
retroel
play
role
hereditari
form
autoimmun
administr
inhibitor
might
amelior
ag
possibl
associ
mutat
gene
associ
ag
myocard
still
unexplor
howev
mutat
caus
singletonmerten
syndrom
allel
locu
may
manifest
cardiomegali
heart
failur
conduct
diseas
syndrom
aortic
calcif
dental
anomali
osteopenia
acroosteolysi
glaucoma
psoriasi
muscl
weak
joint
laxiti
abnorm
faci
trait
broad
forehead
high
anterior
hairlin
smooth
philtrum
thin
upper
vermilion
border
unlik
escap
clinic
detect
addit
recent
experiment
studi
explor
involv
adenosin
deaminas
act
rna
inflammatori
diseas
cancer
host
defens
viral
infect
adar
enzym
regul
rna
metabol
posttranscript
mechan
particular
complex
promot
express
highli
express
cardiac
myocyt
viral
myocard
cultur
cell
suppress
pten
express
preliminari
experiment
studi
suggest
could
play
role
gene
express
viral
myocard
cardiovascular
impact
type
interferonopathi
ag
particular
could
go
beyond
possibl
myocardi
inflamm
expand
primari
pulmonari
hypertens
well
risk
coronari
arteri
diseas
base
current
state
knowledg
myocard
say
infecti
myocard
fact
genet
diseas
absenc
infecti
pathogen
myocard
howev
rigor
attempt
made
establish
equal
exposur
pathogen
develop
myocard
individu
gene
variant
candid
play
role
diseas
susceptibilitypredisposit
contribut
sever
phenotyp
outcom
observ
differ
patient
myocardi
infect
caus
pathogen
noninfecti
myocard
exclud
exogen
toxic
exposur
may
hereditari
basi
strongli
influenc
genet
factor
clinic
difficult
distinguish
acquir
inherit
form
hereditari
form
often
pass
recess
trait
final
inherit
diseas
immunodefici
syndrom
autoinflammatori
diseas
overlap
caus
phenotyp
myocard
may
occur
often
syndrom
disord
mani
identifi
recent
number
report
proven
case
limit
case
report
small
clinic
seri
clinic
area
also
continu
expand
short
term
expect
radic
chang
knowledg
understand
mechan
caus
myocard
critic
point
remain
unsolv
true
myocard
diagnos
tissu
biopsi
least
molecular
imag
techniqu
readili
routin
avail
demonstr
myocardi
edema
inflammatori
interstiti
cell
accept
scientif
literatur
base
nonbiopsi
diagnos
retain
belief
absenc
patholog
evid
diagnos
correct
cardiologist
lead
diagnost
workup
diseas
well
clinic
manag
patient
